English contracts to save up to £150mn
Executive Summary
England’s National Health Service (NHS) believes it can save up to £150 million (US$195 million) per year by launching a competitive tender after a six-month paediatric extension to a supplementary protection certificate (SPC) protecting AbbVie’s Humira (adalimumab) ended on 16 October.